117 related articles for article (PubMed ID: 6702793)
1. Reduction of absolute lymphocyte count in children with recurrent medulloblastoma.
Tomita T; Ammirati M
Am J Dis Child; 1984 Apr; 138(4):392-4. PubMed ID: 6702793
[TBL] [Abstract][Full Text] [Related]
2. Pre-operative neutrophil count and neutrophil-lymphocyte count ratio (NLCR) in predicting the histological grade of paediatric brain tumours: a preliminary study.
Wilson JRF; Saeed F; Tyagi AK; Goodden JR; Sivakumar G; Crimmins D; Elliott M; Picton S; Chumas PD
Acta Neurochir (Wien); 2018 Apr; 160(4):793-800. PubMed ID: 29188366
[TBL] [Abstract][Full Text] [Related]
3. Recurrent medulloblastoma in children.
Nishio S; Fukui M; Takeshita I; Nakagaki H; Kitamura K; Jingu K
Neurol Med Chir (Tokyo); 1986 Jan; 26(1):19-25. PubMed ID: 2425271
[No Abstract] [Full Text] [Related]
4. Pre-treatment lymphopenia and indication of tumor-induced systemic immunosuppression in medulloblastoma.
Patel S; Wang S; Snuderl M; Karajannis MA
J Neurooncol; 2018 Feb; 136(3):541-544. PubMed ID: 29143922
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma in children: a correlation between staging and results of treatment.
Harisiadis L; Chang CH
Int J Radiat Oncol Biol Phys; 1977; 2(9-10):833-41. PubMed ID: 597384
[No Abstract] [Full Text] [Related]
6. Medulloblastoma: a critical approach to the management on the basis of 12 years of experience.
Colangelo M; Daniele B; Ruggiero R; Buonaguro A; Ambrosio A
Childs Nerv Syst; 1987; 3(2):81-4. PubMed ID: 3621232
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
Gururangan S; Reap E; Schmittling R; Kocak M; Reynolds R; Grant G; Onar-Thomas A; Baxter P; Pollack IF; Phillips P; Boyett J; Fouladi M; Mitchell D
Cancer Immunol Immunother; 2017 Dec; 66(12):1589-1595. PubMed ID: 28825123
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of DNA methylation-derived neutrophil-to-lymphocyte ratio and survival in pediatric medulloblastoma.
Arroyo VM; Lupo PJ; Scheurer ME; Rednam SP; Murray J; Okcu MF; Chintagumpala MM; Brown AL
Cancer Epidemiol; 2019 Apr; 59():71-74. PubMed ID: 30703618
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
10. [Medulloblastoma in children].
Hideghety K; Kerr C; Debrigode C; Dubois JB
Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
[No Abstract] [Full Text] [Related]
11. Salvage Therapy for Childhood Medulloblastoma: A Single Center Experience.
Kameda-Smith MM; Wang A; Abdulhadi N; Voth R; Sergeant A; Maharaj A; Bakhshinyan D; Adile AA; Pai AM; Ajani O; Yarascavitch B; Alyman MC; Duckworth J; Samaan MC; Farrokhyar F; Singh SK; Fleming A;
Can J Neurol Sci; 2019 Jul; 46(4):403-414. PubMed ID: 31293232
[TBL] [Abstract][Full Text] [Related]
12. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
13. [Relapse modalities in medulloblastoma].
Di Rocco C; Iannelli A; Tancredi A; Mastrangelo R; Valente A; Riccardi R; Deb G; Donfrancesco A
Pediatr Med Chir; 1994; 16(3):241-5. PubMed ID: 7971445
[TBL] [Abstract][Full Text] [Related]
14. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation.
Caputy AJ; McCullough DC; Manz HJ; Patterson K; Hammock MK
J Neurosurg; 1987 Jan; 66(1):80-7. PubMed ID: 3783262
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure in patients with medulloblastoma.
Jereb B; Reid A; Ahuja RK
Cancer; 1982 Dec; 50(12):2941-7. PubMed ID: 7139584
[No Abstract] [Full Text] [Related]
16. [Medulloblastoma of the cerebellum. Apropos of 120 cases from 1953 to 1982].
Baranzelli MC; Demaille MC; Dhellemmes P; Madelain M; Nuyts JP
Ann Pediatr (Paris); 1986 Feb; 33(2):93-8. PubMed ID: 3963719
[No Abstract] [Full Text] [Related]
17. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging of treatment-associated changes in recurrent and residual medulloblastoma: preliminary observations in three children.
Schubert MI; Wilke M; Müller-Weihrich S; Auer DP
Acta Radiol; 2006 Dec; 47(10):1100-4. PubMed ID: 17135017
[TBL] [Abstract][Full Text] [Related]
19. [Medulloblastoma in adults: report of 13 cases and literature review].
Drissi J; Affane M; Elomrani A; Khouchani M
Pan Afr Med J; 2015; 22():126. PubMed ID: 26889307
[TBL] [Abstract][Full Text] [Related]
20. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
